NeutralRating News & Analysis
4 articles
Market Mood
Summit Therapeutics (SMMT) Receives Neutral Rating from H.C. Wainwright
H.C. Wainwright has reiterated a Neutral stock rating on Summit Therapeutics (SMMT). The firm did not provide specific price targets or other concrete financial metrics in their assessment. This rating reflects the firm's cautious outlook regarding the stock's performance in the current market environment. Investors should note that a Neutral rating suggests a lack of clear direction, which may impact trading decisions.
Read More: Summit Therapeutics (SMMT) Receives Neutral Rating from H.C. Wainwright
Summit Therapeutics (SMMT) Neutral Rating Reaffirmed by H.C. Wainwright
H.C. Wainwright has maintained a Neutral rating on Summit Therapeutics (SMMT). This rating indicates an expectation of limited near-term price movement for the stock. Analysts do not project significant changes in the company's performance based on current market conditions. Investors may want to keep track of any further updates or changes in analysts' assessments that could affect stock performance.
Read More: Summit Therapeutics (SMMT) Neutral Rating Reaffirmed by H.C. Wainwright
Rivian (RIVN) Stock Rated Neutral at $19 by Cantor Fitzgerald
Cantor Fitzgerald has maintained a Neutral rating on Rivian (RIVN) stock with a price target of $19. This rating reflects the firm's assessment of Rivian's performance and potential in the current market environment. The price point of $19 suggests that analysts expect limited volatility around this level. Monitoring Rivian's stock will provide insights into investor sentiment and market dynamics regarding electric vehicle manufacturers.
Read More: Rivian (RIVN) Stock Rated Neutral at $19 by Cantor Fitzgerald
H.C. Wainwright Maintains Neutral Rating on Phunware Stock at $2
H.C. Wainwright has reiterated a Neutral rating for Phunware Inc., maintaining the stock price target at $2. This rating reflects the firm's outlook on the company's performance and its implications for investors. The stability in the rating might influence market perceptions of Phunware's stock, particularly among analysts and investors monitoring tech sector stocks.
Read More: H.C. Wainwright Maintains Neutral Rating on Phunware Stock at $2